Renova Therapeutics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC
  • (In Progress)

  • Investors
  • 4

Renova Therapeutics General Information

Description

Operator of a biotechnology research company intended to advance gene therapies for chronic conditions involving cardiovascular and metabolic disease. The company offers targeted gene therapy modalities and proprietary delivery approaches, enabling healthcare providers, researchers, and patients access to treatments that address the underlying drivers of long-term disease progression.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 701 Palomar Airport Road
  • Suite 300
  • Carlsbad, CA 92011
  • United States
+1 (858)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 701 Palomar Airport Road
  • Suite 300
  • Carlsbad, CA 92011
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Renova Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC In Progress Clinical Trials - Phase 2
10. Later Stage VC 02-Feb-2024 Completed Product Development
9. Grant 20-Sep-2019 Completed Product Development
8. Later Stage VC (Series D1) 31-Jan-2017 Completed Product Development
7. Later Stage VC (Series D) 23-Feb-2016 Completed Product Development
6. Grant 01-Jan-2016 Completed Product Development
5. Later Stage VC (Series C) 30-Sep-2014 Completed Product Development
4. Early Stage VC (Series B) 25-Feb-2012 Completed Product Development
3. Grant 02-Sep-2011 $250K $3.05M Completed Startup
2. Early Stage VC (Series A) 10-Aug-2009 $3.05M $3.05M Completed Startup
To view Renova Therapeutics’s complete valuation and funding history, request access »

Renova Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B 320,292 $0.001000 $1.23 $24.6 $24.6 1x $24.6 10.46%
Series A 305,000 $0.001000 $0.5 $10 $10 1x $10 9.96%
To view Renova Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Renova Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology research company intended to advance gene therapies for chronic conditions involving cardiov
Pharmaceuticals
Carlsbad, CA

San Rafael, CA
 

Torrance, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Renova Therapeutics Competitors (85)

One of Renova Therapeutics’s 85 competitors is BioMarin Pharmaceutical, a Formerly PE-Backed company based in San Rafael, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioMarin Pharmaceutical Formerly PE-Backed San Rafael, CA
Emmaus Life Sciences Formerly VC-backed Torrance, CA
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA
Pfizer (Vienna) Corporation Vienna, Austria
Jaguar Gene Therapy Venture Capital-Backed Lake Forest, IL
You’re viewing 5 of 85 competitors. Get the full list »

Renova Therapeutics Patents

Renova Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018090036-A1 Method of protection for cardiac tissue Inactive 14-Nov-2016
WO-2018090042-A1 Methods of treating heart failure Inactive 14-Nov-2016

Renova Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Heart, Lung, and Blood Institute Government
Biobrit Venture Capital Minority
National Institutes of Health Government
University of California, San Diego University
To view Renova Therapeutics’s complete investors history, request access »

Renova Therapeutics FAQs

  • When was Renova Therapeutics founded?

    Renova Therapeutics was founded in 2009.

  • Where is Renova Therapeutics headquartered?

    Renova Therapeutics is headquartered in Carlsbad, CA.

  • What industry is Renova Therapeutics in?

    Renova Therapeutics’s primary industry is Pharmaceuticals.

  • Is Renova Therapeutics a private or public company?

    Renova Therapeutics is a Private company.

  • What is Renova Therapeutics’s current revenue?

    The current revenue for Renova Therapeutics is .

  • How much funding has Renova Therapeutics raised over time?

    Renova Therapeutics has raised $78.1M.

  • Who are Renova Therapeutics’s investors?

    National Heart, Lung, and Blood Institute, Biobrit, National Institutes of Health, and University of California, San Diego have invested in Renova Therapeutics.

  • Who are Renova Therapeutics’s competitors?

    BioMarin Pharmaceutical, Emmaus Life Sciences, Dicerna Pharmaceuticals, Pfizer (Vienna), and Jaguar Gene Therapy are some of the 85 competitors of Renova Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process